SCHEMBL3757639

SCHEMBL3757639

O=C1CCCc2c1sc(N1CCOCC1)c2Cc1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 3/20 0.41
PIK3CA P42336 3/20 0.41
PIK3CB P42338 3/20 0.41
PIK3CG P48736 3/20 0.41
ALDH1A1 P00352 8/20 0.39
SMN1; SMN2 Q16637 3/20 0.39
HTT P42858 3/20 0.39
KMT2A Q03164 1/20 0.39
KIF11 P52732 1/20 0.39
KDM4E B2RXH2 5/20 0.38
HPGD P15428 4/20 0.38
MAPT P10636 4/20 0.38
GAA P10253 2/20 0.38
HTR2C P28335 1/20 0.38
HTR2B P41595 1/20 0.38
LMNA P02545 1/20 0.37
GLA P06280 1/20 0.37
RXFP1 Q9HBX9 1/20 0.37
HSD17B10 Q99714 1/20 0.36
PRKDC P78527 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3764951 0.90 PIK3CD (0.40) PIK3CDPIK3CAPIK3CBPIK3CGALDH1A1
SCHEMBL3751674 0.80 HSD17B10 (0.43) PIK3CDPIK3CAPIK3CBPIK3CGALDH1A1
SCHEMBL16161774 0.76 GRM5 (0.46) PIK3CDPIK3CAPIK3CBPIK3CGHSD17B10
SCHEMBL3759549 0.75 PRKDC (0.44) PIK3CDPIK3CAPIK3CBPIK3CGHSD17B10
SCHEMBL3767340 0.74 ALDH1A1 (0.46) PIK3CAALDH1A1SMN1; SMN2KMT2AKDM4E
SCHEMBL3764986 0.73 PIK3CD (0.49) PIK3CDPIK3CAPIK3CBPIK3CGALDH1A1
SCHEMBL3765735 0.73 PIK3CD (0.49) PIK3CDPIK3CAPIK3CBPIK3CGALDH1A1
SCHEMBL4569738 0.71 PIK3CA (0.44) PIK3CDPIK3CAPIK3CBPIK3CGALDH1A1
SCHEMBL3766049 0.70 PIK3CA (0.46) PIK3CDPIK3CAPIK3CBPIK3CGALDH1A1
SCHEMBL360530 0.67 ALDH1A1 (0.67) PIK3CDPIK3CAPIK3CBPIK3CGALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2029570-B1 FUSED THIOPHENE DERIVATIVES AS KINASE INHIBITORS UCB PHARMA SA (BE) 2014-10-15 EP disclosed
US-8324204-B2 Fused thiophene derivatives as kinase inhibitors UCB PHARMA SA (BE) 2012-12-04 US disclosed
US-20100305066-A1 Fused Thiophene Derivatives as Kinase Inhibitors UCB PHARMA S.A. (BE) 2010-12-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100305066-A1 Fused Thiophene Derivatives as Kinase Inhibitors PIKFYVE, PI4KA, PIK3CA PIK3CD 9/4885PIK3CA 3/4885PIK3CB 11/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.